Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene

Circulation

Volumn 97, Issue 22, 1998, Pages 2230-2236

  Charron, Philippe ^a   Dubourg, Olivier ^b   Desnos, Michel ^c   Bennaceur, Mohammed ^e   Carrier, Lucie ^a   Camproux, Anne Claude ^a   Isnard, Richard ^a   Hagege, Albert ^c   Langlard, Jean Marc ^d   Bonne, Gisele ^a   Richard, Pascale ^a   Hainque, Bernard ^a   Bouhour, Jean Brieuc ^d   Schwartz, Ketty ^a   Komajda, Michel ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c Hopital Boucicaut   (France)

^d CHU de Nantes   (France)

^e Hop Pitie Salpetriere ^*

Author keywords

Cardiomyopathy; Genetics; Hypertrophy; Myosin; Prognosis

Indexed keywords

BINDING PROTEIN; MYOSIN; MYOSIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOM;

EID: 0032499634     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.22.2230     Document Type: Article

References (33)

1. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology. and therapy. N Engl J Med. 1987;316:780-789, 844-852.
2. Wigle ED, Rakowski H, Kimball BP, Williams WG, Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92:1680-1692.
3. Spirito P, Seidman CE, McKenna WJ, Maron BJ, The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.
4. Frenneaux MP, Counihan PJ, Caforio ALP, Chikamori T, MacKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation. 1990;82:1995-2002.
5. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, Vosberg H-P, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999-1006.
6. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman C. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701-712.
7. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Weissenbach J, Vosberg HP, Fiszman M, Komajda M, Schwanz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438-440.
8. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna W, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
9. Poetter K, Jiang HE, Hassenzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either of the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13:63-69.
10. Kimura A, Harada H, Park J-E, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang T-H, Choo J-A, Chung K-S, Hasegawa A, Nagai R, Qkazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 1997;19:379-382.
11. Watkins HG, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108-1114.
12. Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation. 1995;91:532-540.
13. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 1995;92:1336-1347.
14. Watkins H, McKenna W, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058-1064.
15. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H. Sudden death due to troponin T mutations. J Am Coll Cardiol. 1997;29:549-555.
16. Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Bonne G, Carrier L, Tesson F, Bouhour J-B, Buzzí J-C, Feíngold J, Schwanz K, Komajda M. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy associated: a comparison between mutations in the cardiac protein-C and the β-myosin heavy chain genes. Ear Heart J. 1998;19:139-145.
17. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour J-B. Dubourg O, Desnos M, Hagege AA, Trent RJ, Komajda M, Fiszman M, Schwanz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 1997;80:427-434.
18. Dausse E, Komajda M, Fetler L, Dubourg O, Dufour C, Carrier L, Winesnewsky C, Bercovící J, Hengstenberg C, AI-Mahdawi S, Isnard R, Hagege A, Bouhour JB, Desnos M, Beckmann JS, Weissenbach J, Schwanz K, Guicheney P. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hot spot for mutations in the β myosin heavy chain gene. J Clin Invest. 1993;92:2807-2813.
19. Dufour C, Dausse E, Fetler L, Dubourg O, Bouhour JB, Vosberg H-P, Guicheney P, Komajda M, Schwanz K. Identification of a mutathypertrophicion near a functional site of the β cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1994;26:1241-1247.
20. Richard P, Tesson F, Hainque B, Mathieu B, Carrier L, Komajda M, Schwanz K, Guicheney P. β-Myosin heavy chain gene mutations screening in 18 unrelated families with familial hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1996;28:A65. Abstract.
21. Dubourg O, Isnard R, Hagège A, Jondeau G, Desnos M, Sacrez A, Bouhour JB, Messmer Pellenc P, Millaire A, Fetler L, Guicheney P, Schwanz K, Komajda M. Doppler echocardiography in familial hypertrophic cardiomyopathy: the French Cooperative Study. Echocardiography. 1995;12:235-240.
22. Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Millaire A, Carrier L, Bonne G, Tesson F, Richard P, Bouhour J-B, Schwanz K, Komajda M. Diagnostic value of electrocardiograph v and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation. 1997;96:214-219.
23. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990;15:808-813.
24. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne G, Guicheney P, Hainque B, Bouhour J-B, Mallet A, Feingold J, Schwanz K, Komajda M. Penetrance of familial hypertrophic cardiomyopathy. Genet Count. 1997;8:107-114.
25. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation, 1980;62:1054-1066.
26. Romhilt DW, Estes EH. Point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752-758.
27. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
28. Rotbauer W, Gautel M, Zeheleln J, Labeit S, Franz WM, Fischer C, Volrath B, Mall G, Dietz R, Kubler W, Katus HU. Novel splice site donor mutation in the cardiac myosin binding protein C gene in familial hypertrophic cardiomyopathy. J Clin Invest. 1997;100:475-482.
29. Watkins H, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet. 1995;91:532-540.
30. Spirito P, Maron BJ, Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1987;9:1013-1017.
31. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation. 1994;89:22-32.
32. Forissier J-F, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend P, Yacoub MH, Faure S, Dubourg O, Millaire A, Hagege AA, Desnos M, Komajda M, Schwanz K. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation. 1996;94:3069-3073.
33. Morris JJ, Estes EH, Whalen RE, Thompson HK, Mclntosh HD. P-wave analysis in valvular heart disease. Circulation. 1964;29:242-252.